A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants

Clinical trial NCT07022119 · COMPLETED

Trial details

NCT number: NCT07022119
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Start date: 2025-06-12
Primary completion: 2026-02-24
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.